The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

GP leaders have warned that the rollout of the weight loss drug tirzepatide (Mounjaro, Eli Lilly) will still have ...

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Tirzepatide had received approval in a single-dose prefilled pen format in January 2024 for use as an adjunct to diet and ...

The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...

Lilly's rival Danish firm Novo Nordisk is also working to bring its obesity drug Wegovy (Semaglutide) to India soon, and ...

In the trail, 11 participants in the azelaprag group exhibited transaminase elevations without significant symptoms.

NICE has accepted a request from NHS England to slow down the roll out of weight-loss drug tirzepatide but GP workload ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...

Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to ...